Trade-Offs in the Effects of the Apolipoprotein E Polymorphism on Risks of Diseases of the Heart, Cancer, and Neurodegenerative Disorders: Insights on Mechanisms from the Long Life Family Study

Rejuvenation Research

Volumn 18, Issue 2, 2015, Pages 128-135

  Kulminski, Alexander M ^a   Arbeev, Konstantin G ^a   Culminskaya, Irina ^a   Ukraintseva, Svetlana V ^a   Stallard, Eric ^a   Province, Michael A ^b   Yashin, Anatoli I ^a  

^a DUKE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGE; AGED; ALLELE; ARTICLE; CLINICAL RESEARCH; DEGENERATIVE DISEASE; DNA POLYMORPHISM; FEMALE; GENDER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEALTH; HEART DISEASE; HEART INFARCTION; HUMAN; LONG LIFE FAMILY STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEOPLASM; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGENY; RETROSPECTIVE STUDY; SPOUSE; VERY ELDERLY; ADULT; AGING; CLINICAL TRIAL; COMPARATIVE STUDY; DENMARK; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART DISEASES; HEREDITY; KAPLAN MEIER METHOD; LIFE EXPECTANCY; LONGITUDINAL STUDY; MIDDLE AGED; MULTICENTER STUDY; NEOPLASMS; NEURODEGENERATIVE DISEASES; ODDS RATIO; PEDIGREE; PROPORTIONAL HAZARDS MODEL; PROTECTION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEIN E4; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART DISEASES; HEREDITY; HUMANS; KAPLAN-MEIER ESTIMATE; LIFE EXPECTANCY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; NEURODEGENERATIVE DISEASES; ODDS RATIO; PEDIGREE; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 84928490466     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2014.1616     Document Type: Article

References (53)

1. Sierra F, Hadley E, Suzman R, Hodes R. Prospects for life span extension. Annu Rev Med 2009;60:457-469.
2. Olshansky SJ, Perry D, Miller RA, Butler RN. Pursuing the longevity dividend: Scientific goals for an aging world. Ann NY Acad Sci 2007;1114:11-13.
3. Gibson G. Rare and common variants: Twenty arguments. Nat Rev Genet 2011;13:135-145.
4. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010;11:446-450.
5. Martin GM, Bergman A, Barzilai N. Genetic determinants of human health span and life span: Progress and new opportunities. PLoS Genet 2007;3:e125.
6. Franco OH, Karnik K, Osborne G, Ordovas JM, Catt M, van der Ouderaa F. Changing course in ageing research: The healthy ageing phenotype. Maturitas 2009;63:13-19.
7. Hershcopf RJ, Elahi D, Andres R, Baldwin HL, Raizes GS, Schocken DD, Tobin JD. Longitudinal changes in serum cholesterol in man: An epidemiologic search for an etiology. J Chronic Dis 1982;35:101-114.
8. Scheen AJ. Diabetes mellitus in the elderly: Insulin resistance and/or impaired insulin secretion? Diabetes Metab 2005;31(Spec No 2):5S27-25S34.
9. Yashin AI, Akushevich IV, Arbeev KG, Akushevich L, Ukraintseva SV, Kulminski A. Insights on aging and exceptional longevity from longitudinal data: Novel findings from the Framingham Heart Study. Age 2006;28:363-374.
10. Sheu Y, Cauley JA, Wheeler VW, Patrick AL, Bunker CH, Ensrud KE, Orwoll ES, Zmuda JM. Age-related decline in bone density among ethnically diverse older men. Osteoporos Int 2011;22:599-605.
11. Akushevich I, Kravchenko J, Ukraintseva S, Arbeev K, Yashin AI. Age patterns of incidence of geriatric disease in the U.S. elderly population: Medicare-based analysis. J Am Geriatr Soc 2012;60:323-327.
12. Finch CE, Tanzi RE. Genetics of aging. Science 1997;278:407-411.
13. Jazwinski SM. Biological aging research today: Potential, peeves, and problems. Exp Gerontol 2002;37:1141-1146.
14. Sivakumaran S, Agakov F, Theodoratou E, Prendergast JG, Zgaga L, Manolio T, Rudan I, McKeigue P, Wilson JF, Campbell H. Abundant pleiotropy in human complex diseases and traits. Am J Hum Genet 2011;89:607-618.
15. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL. The human disease network. Proc Natl Acad Sci USA 2007;104:8685-8690.
16. Frazer KA, Murray SS, Schork NJ, Topol EJ. Human genetic variation and its contribution to complex traits. Nat Rev Genet 2009;10:241-251.
17. Kulminski AM, Culminskaya IV, Ukraintseva SV, Arbeev KG, Akushevich I, Land KC, Yashin AI. Polymorphisms in the ACE and ADRB2 genes and risks of aging-associated phenotypes: The case of myocardial infarction. Rejuvenation Res 2010;13:13-21.
18. Kulminski AM, Culminskaya I, Ukraintseva SV, Arbeev KG, Arbeeva L, Wu D, Akushevich I, Land KC, Yashin AI. Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan. Aging Cell 2011;10:533-541.
19. Kulminski AM, Ukraintseva SV, Arbeev KG, Manton KG, Oshima J, Martin GM, Il'yasova D, Yashin AI. Health-protective and adverse effects of the apolipoprotein E epsilon2 allele in older men. J Am Geriatr Soc 2008;56:478-483.
20. Crespi BJ. The origins and evolution of genetic disease risk in modern humans. Ann NY Acad Sci 2010;1206:80-109.
21. Wang K, Baldassano R, Zhang H, Qu HQ, Imielinski M, Kugathasan S, Annese V, Dubinsky M, Rotter JI, Russell RK, Bradfield JP, Sleiman PM, Glessner JT, Walters T, Hou C, Kim C, Frackelton EC, Garris M, Doran J, Romano C, Catassi C, Van Limbergen J, Guthery SL, Denson L, Piccoli D, Silverberg MS, Stanley CA, Monos D, Wilson DC, Griffiths A, Grant SF, Satsangi J, Polychronakos C, Hakonarson H. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Hum Mol Genet 2010;19:2059-2067.
22. Barnes JA, Dix DJ, Collins BW, Luft C, Allen JW. Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia. Cell Stress Chaperones 2001;6:316-325.
23. Williams GC. Pleiotropy, natural-selection, and the evolution of senescence. Evolution 1957;11:398-411.
24. Martin GM. Modalities of gene action predicted by the classical evolutionary biological theory of aging. Ann NY Acad Sci 2007;1100:14-20.
25. Williams PD, Day T. Antagonistic pleiotropy, mortality source interactions, and the evolutionary theory of senescence. Evolution 2003;57:1478-1488.
26. Kulminski AM, Culminskaya I, Ukraintseva SV, Arbeev KG, Land KC, Yashin AI. Beta2-adrenergic receptor gene polymorphisms as systemic determinants of healthy aging in an evolutionary context. Mech Ageing Dev 2010;131:338-345.
27. Summers K, Crespi BJ. Xmrks the spot: Life history tradeoffs, sexual selection and the evolutionary ecology of oncogenesis. Mol Ecol 2010;19:3022-3024.
28. Alexander DM, Williams LM, Gatt JM, Dobson-Stone C, Kuan SA, Todd EG, Schofield PR, Cooper NJ, Gordon E. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biol Psychol 2007;75:229-238.
29. Schnebel EM, Grossfield J. Antagonistic pleiotropy - an interspecific Drosophila comparison. Evolution 1988;42:306-311.
30. De Benedictis G, Carotenuto L, Carrieri G, De Luca M, Falcone E, Rose G, Yashin AI, Bonafe M, Franceschi C. Age-related changes of the 3′ APOB-VNTR genotype pool in ageing cohorts. Ann Hum Genet 1998;62(Pt 2):115-122.
31. Ilveskoski E, Perola M, Lehtimaki T, Laippala P, Savolainen V, Pajarinen J, Penttila A, Lalu KH, Mannikko A, Liesto KK, Koivula T, Karhunen PJ. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: An autopsy study. Circulation 1999;100:608-613.
32. Yashin AI, Ukraintseva SV, De Benedictis G, Anisimov VN, Butov AA, Arbeev K, Jdanov DA, Boiko SI, Begun AS, Bonafe M, Franceschi C. Have the oldest old adults ever been frail in the past? A hypothesis that explains modern trends in survival. J Gerontol A Biol Sci Med Sci 2001;56:B432-B442.
33. Bergman A, Atzmon G, Ye K, MacCarthy T, Barzilai N. Buffering mechanisms in aging: A systems approach toward uncovering the genetic component of aging. PLoS Comput Biol 2007;3:e170.
34. Kulminski AM, Culminskaya I, Arbeev KG, Ukraintseva SV, Arbeeva L, Yashin AI. Trade-off in the effect of the APOE gene on the ages at onset of cardiocascular disease and cancer across ages, gender, and human generations. Rejuvenation Res 2013;16:28-34.
35. Jarvik GP, Goode EL, Austin MA, Auwerx J, Deeb S, Schellenberg GD, Reed T. Evidence that the apolipoprotein E-genotype effects on lipid levels can change with age in males: A longitudinal analysis. Am J Hum Genet 1997;61:171-181.
36. Lasky-Su J, Lyon HN, Emilsson V, Heid IM, Molony C, Raby BA, Lazarus R, Klanderman B, Soto-Quiros ME, Avila L, Silverman EK, Thorleifsson G, Thorsteinsdottir U, Kronenberg F, Vollmert C, Illig T, Fox CS, Levy D, Laird N, Ding X, McQueen MB, Butler J, Ardlie K, Papoutsakis C, Dedoussis G, O'Donnell CJ, Wichmann HE, Celedon JC, Schadt E, Hirschhorn J, Weiss ST, Stefansson K, Lange C. On the replication of genetic associations: Timing can be everything! Am J Hum Genet. Apr 2008;82(4):849-858.
37. Sebastiani P, Hadley EC, Province M, Christensen K, Rossi W, Perls TT, Ash AS. A family longevity selection score: ranking sibships by their longevity, size, and availability for study. Am J Epidemiol 2009;170:1555-1562.
38. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53:441-449.
39. Yashin AI, Arbeev KG, Kulminski A, Borecki I, Christensen K, Barmada M, Hadley E, Rossi W, Lee JH, Cheng R, Elo IT. "Predicting" parental longevity from offspring endophenotypes: Data from the Long Life Family Study (LLFS). Mech Ageing Dev 2010;131:215-222.
40. Schupf N, Barral S, Perls T, Newman A, Christensen K, Thyagarajan B, Province M, Rossi WK, Mayeux R. Apolipoprotein E and familial longevity. Neurobiol Aging 2013;34:1287-1291.
41. Kulminski AM. Unraveling genetic origin of aging-related traits: Evolving concepts. Rejuvenation Res 2013;16:304-312.
42. Corella D, Ordovas JM. Aging and cardiovascular diseases: The role of gene-diet interactions. Ageing Res Rev 2014;18C:53-73.
43. Kulminski AM, Culminskaya I, Arbeev KG, Ukraintseva SV, Stallard E, Arbeeva L, Yashin AI. The role of lipid-related genes, aging-related processes, and environment in healthspan. Aging Cell 2013;12:237-246.
44. Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 2004;141:137-147.
45. Wilson PW, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-1255.
46. Tabares-Seisdedos R, Rubenstein JL. Inverse cancer comorbidity: A serendipitous opportunity to gain insight into CNS disorders. Nat Rev Neurosci 2013;14:293-304.
47. Yashin AI, Wu D, Arbeev KG, Ukraintseva SV. Polygenic effects of common single-nucleotide polymorphisms on life span: When association meets causality. Rejuvenation Res 2012;15:381-394.
48. Day-Williams AG, Zeggini E. The effect of next-generation sequencing technology on complex trait research. Eur J Clin Invest 2011;41:561-567.
49. McClellan J, King MC. Genetic heterogeneity in human disease. Cell 2010;141:210-217.
50. Neale BM, Sham PC. The future of association studies: Gene-based analysis and replication. Am J Hum Genet 2004;75:353-362.
51. Luo L, Peng G, Zhu Y, Dong H, Amos CI, Xiong M. Genome-wide gene and pathway analysis. Eur J Hum Genet 2010;18:1045-1053.
52. Christensen K, Johnson TE, Vaupel JW. The quest for genetic determinants of human longevity: Challenges and insights. Nat Rev Genet 2006;7:436-448.
53. Kolovou G, Damaskos D, Anagnostopoulou K, Cokkinos DV. Apolipoprotein E gene polymorphism and gender. Ann Clin Lab Sci 2009;39:120-133.